메뉴 건너뛰기




Volumn 138, Issue 1, 2013, Pages 215-223

Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: A multi-institutional retrospective study

Author keywords

Adjuvant chemotherapy; HER2 positive breast cancer; Propensity score; Stage I breast cancer; Trastuzumab; Triple negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB;

EID: 84874645814     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2423-3     Document Type: Article
Times cited : (22)

References (49)
  • 1
    • 84861527388 scopus 로고    scopus 로고
    • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
    • 10.1038/nature10983
    • Curtis C, Shah SP, Chin SF et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. doi: 10.1038/nature10983
    • (2012) Nature
    • Curtis, C.1    Shah, S.P.2    Chin, S.F.3
  • 2
    • 79960980007 scopus 로고    scopus 로고
    • Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011
    • 10.1093/annonc/mdr304 21709140 10.1093/annonc/mdr304 1:STN:280: DC%2BC3Mjhs1ygug%3D%3D
    • Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, Panel M (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol 22:1736-1747. doi: 10.1093/annonc/mdr304
    • (2011) Ann Oncol , vol.22 , pp. 1736-1747
    • Goldhirsch, A.1    Wood, W.C.2    Coates, A.S.3    Gelber, R.D.4    Thurlimann, B.5    Senn, H.J.6    Panel, M.7
  • 3
    • 77950512587 scopus 로고    scopus 로고
    • Breast cancer subtypes and the risk of local and regional relapse
    • 10.1200/JCO.2009.24.9284 20194857 10.1200/JCO.2009.24.9284
    • Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684-1691. doi: 10.1200/JCO.2009.24.9284
    • (2010) J Clin Oncol , vol.28 , pp. 1684-1691
    • Voduc, K.D.1    Cheang, M.C.2    Tyldesley, S.3    Gelmon, K.4    Nielsen, T.O.5    Kennecke, H.6
  • 4
    • 35248895346 scopus 로고    scopus 로고
    • HER2 and response to paclitaxel in node-positive breast cancer
    • Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, Cancer, Leukemia Group BI 10.1056/NEJMoa071167 10.1056/NEJMoa071167
    • Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, Cancer, Leukemia Group BI (2007) HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 357:1496-1506. doi: 10.1056/NEJMoa071167
    • (2007) N Engl J Med , vol.357 , pp. 1496-1506
  • 6
    • 26844503270 scopus 로고    scopus 로고
    • Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
    • Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD, Herceptin Adjuvant Trial Study T 10.1056/NEJMoa052306 10.1056/NEJMoa052306
    • Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD, Herceptin Adjuvant Trial Study T (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353:1659-1672. doi: 10.1056/NEJMoa052306
    • (2005) N Engl J Med , vol.353 , pp. 1659-1672
  • 8
    • 33646439130 scopus 로고    scopus 로고
    • Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a, bN0M0): A review of the literature
    • 10.1200/JCO.2005.02.8035 16648513 10.1200/JCO.2005.02.8035
    • Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN (2006) Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a, bN0M0): a review of the literature. J Clin Oncol 24:2113-2122. doi: 10.1200/JCO.2005.02.8035
    • (2006) J Clin Oncol , vol.24 , pp. 2113-2122
    • Hanrahan, E.O.1    Valero, V.2    Gonzalez-Angulo, A.M.3    Hortobagyi, G.N.4
  • 9
    • 0035900920 scopus 로고    scopus 로고
    • Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
    • 11208880 10.1093/jnci/93.2.112 1:STN:280:DC%2BD3M7nvF2ltg%3D%3D
    • Fisher B, Dignam J, Tan-Chiu E, Anderson S, Fisher ER, Wittliff JL, Wolmark N (2001) Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst 93:112-120
    • (2001) J Natl Cancer Inst , vol.93 , pp. 112-120
    • Fisher, B.1    Dignam, J.2    Tan-Chiu, E.3    Anderson, S.4    Fisher, E.R.5    Wittliff, J.L.6    Wolmark, N.7
  • 16
    • 84874662033 scopus 로고    scopus 로고
    • Impact of adjuvant chemotherapy on recurrence-free survival in patients with pT1a/b hormone-negative and HER2-positive breast cancer
    • abstract 1034
    • Migdady Y, Sikov WM, Sakr BJ, Olszewski AJ (2012) Impact of adjuvant chemotherapy on recurrence-free survival in patients with pT1a/b hormone-negative and HER2-positive breast cancer. J Clin Oncol 30, No 15-suppl: abstract 1034
    • (2012) J Clin Oncol , vol.30 , Issue.15 SUPPL.
    • Migdady, Y.1    Sikov, W.M.2    Sakr, B.J.3    Olszewski, A.J.4
  • 17
    • 77954526150 scopus 로고    scopus 로고
    • American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    • 10.1200/JCO.2009.25.6529 20404251 10.1200/JCO.2009.25.6529
    • Hammond ME, Hayes DF, Dowsett M et al (2010) American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795. doi: 10.1200/JCO.2009.25.6529
    • (2010) J Clin Oncol , vol.28 , pp. 2784-2795
    • Hammond, M.E.1    Hayes, D.F.2    Dowsett, M.3
  • 18
    • 33847147313 scopus 로고    scopus 로고
    • American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    • 10.1200/JCO.2006.09.2775 17159189 10.1200/JCO.2006.09.2775 1:CAS:528:DC%2BD2sXht1ejs7Y%3D
    • Wolff AC, Hammond ME, Schwartz JN et al (2007) American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118-145. doi: 10.1200/JCO.2006.09.2775
    • (2007) J Clin Oncol , vol.25 , pp. 118-145
    • Wolff, A.C.1    Hammond, M.E.2    Schwartz, J.N.3
  • 20
    • 79958704133 scopus 로고    scopus 로고
    • An introduction to propensity score methods for reducing the effects of confounding in observational studies
    • 10.1080/00273171.2011.568786 10.1080/00273171.2011.568786
    • Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399-424. doi: 10.1080/00273171.2011.568786
    • (2011) Multivar Behav Res , vol.46 , pp. 399-424
    • Austin, P.C.1
  • 22
    • 0041626110 scopus 로고    scopus 로고
    • Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders
    • 12882951 10.1093/aje/kwg115
    • Cepeda MS, Boston R, Farrar JT, Strom BL (2003) Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158:280-287
    • (2003) Am J Epidemiol , vol.158 , pp. 280-287
    • Cepeda, M.S.1    Boston, R.2    Farrar, J.T.3    Strom, B.L.4
  • 23
    • 0033839024 scopus 로고    scopus 로고
    • Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
    • 10955409 10.1097/00001648-200009000-00012 1:STN:280: DC%2BD3M%2FntlSnsA%3D%3D
    • Hernan MA, Brumback B, Robins JM (2000) Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11:561-570
    • (2000) Epidemiology , vol.11 , pp. 561-570
    • Hernan, M.A.1    Brumback, B.2    Robins, J.M.3
  • 24
    • 51749124303 scopus 로고    scopus 로고
    • Constructing inverse probability weights for marginal structural models
    • 10.1093/aje/kwn164 18682488 10.1093/aje/kwn164
    • Cole SR, Hernan MA (2008) Constructing inverse probability weights for marginal structural models. Am J Epidemiol 168:656-664. doi: 10.1093/aje/kwn164
    • (2008) Am J Epidemiol , vol.168 , pp. 656-664
    • Cole, S.R.1    Hernan, M.A.2
  • 25
    • 77957806232 scopus 로고    scopus 로고
    • Matching methods for causal inference: A review and a look forward
    • 10.1214/09-STS313 20871802 10.1214/09-STS313
    • Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25:1-21. doi: 10.1214/09-STS313
    • (2010) Stat Sci , vol.25 , pp. 1-21
    • Stuart, E.A.1
  • 26
    • 70449365700 scopus 로고    scopus 로고
    • Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
    • 10.1002/sim.3697 19757444 10.1002/sim.3697
    • Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083-3107. doi: 10.1002/sim.3697
    • (2009) Stat Med , vol.28 , pp. 3083-3107
    • Austin, P.C.1
  • 27
    • 77957301897 scopus 로고    scopus 로고
    • Treatment effects in the presence of unmeasured confounding: Dealing with observations in the tails of the propensity score distribution - A simulation study
    • 10.1093/aje/kwq198 20716704 10.1093/aje/kwq198
    • Sturmer T, Rothman KJ, Avorn J, Glynn RJ (2010) Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution-a simulation study. Am J Epidemiol 172:843-854. doi: 10.1093/aje/kwq198
    • (2010) Am J Epidemiol , vol.172 , pp. 843-854
    • Sturmer, T.1    Rothman, K.J.2    Avorn, J.3    Glynn, R.J.4
  • 28
    • 50549102861 scopus 로고    scopus 로고
    • Choice and interpretation of statistical tests used when competing risks are present
    • 10.1200/JCO.2007.12.9866 18711194 10.1200/JCO.2007.12.9866
    • Dignam JJ, Kocherginsky MN (2008) Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26:4027-4034. doi: 10.1200/JCO.2007.12.9866
    • (2008) J Clin Oncol , vol.26 , pp. 4027-4034
    • Dignam, J.J.1    Kocherginsky, M.N.2
  • 29
    • 78049445066 scopus 로고    scopus 로고
    • Pitfalls of using composite primary end points in the presence of competing risks
    • 10.1200/JCO.2010.30.2802 20713860 10.1200/JCO.2010.30.2802
    • Mell LK, Jeong JH (2010) Pitfalls of using composite primary end points in the presence of competing risks. J Clin Oncol 28:4297-4299. doi: 10.1200/JCO.2010.30.2802
    • (2010) J Clin Oncol , vol.28 , pp. 4297-4299
    • Mell, L.K.1    Jeong, J.H.2
  • 30
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistribution of a competing risk
    • 10.1080/01621459.1999.10474144
    • Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Fine, J.P.1    Gray, R.J.2
  • 31
    • 80155164070 scopus 로고    scopus 로고
    • Coping with uncertainty: T1a, bN0M0 HER2-positive breast cancer, do we have a treatment threshold?
    • 10.1093/annonc/mdq786 21406473 10.1093/annonc/mdq786 1:STN:280: DC%2BC3MbjsFSgsw%3D%3D
    • Kelly CM, Pritchard KI, Trudeau M, Andreopoulou E, Hess K, Pusztai L (2011) Coping with uncertainty: T1a, bN0M0 HER2-positive breast cancer, do we have a treatment threshold? Ann Oncol 22:2387-2393. doi: 10.1093/annonc/mdq786
    • (2011) Ann Oncol , vol.22 , pp. 2387-2393
    • Kelly, C.M.1    Pritchard, K.I.2    Trudeau, M.3    Andreopoulou, E.4    Hess, K.5    Pusztai, L.6
  • 33
    • 78650295428 scopus 로고    scopus 로고
    • Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller
    • 10.1016/j.ejso.2010.10.003 21093206 10.1016/j.ejso.2010.10.003 1:STN:280:DC%2BC3M%2FjsFCmtg%3D%3D
    • Lai HW, Kuo SJ, Chen LS, Chi CW, Chen ST, Chang TW, Chen DR (2011) Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller. Eur J Surg Oncol 37:18-24. doi: 10.1016/j.ejso.2010.10.003
    • (2011) Eur J Surg Oncol , vol.37 , pp. 18-24
    • Lai, H.W.1    Kuo, S.J.2    Chen, L.S.3    Chi, C.W.4    Chen, S.T.5    Chang, T.W.6    Chen, D.R.7
  • 34
    • 77958571366 scopus 로고    scopus 로고
    • Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status
    • 10.1634/theoncologist.2010-0036 20930097 10.1634/theoncologist.2010-0036 1:CAS:528:DC%2BC3cXhsFyqsrbI
    • Amar S, McCullough AE, Tan W, Geiger XJ, Boughey JC, McNeil RB, Coppola KE, McLaughlin SA, Palmieri FM, Perez EA (2010) Prognosis and outcome of small (≤1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status. Oncologist 15:1043-1049. doi: 10.1634/theoncologist.2010-0036
    • (2010) Oncologist , vol.15 , pp. 1043-1049
    • Amar, S.1    McCullough, A.E.2    Tan, W.3    Geiger, X.J.4    Boughey, J.C.5    McNeil, R.B.6    Coppola, K.E.7    McLaughlin, S.A.8    Palmieri, F.M.9    Perez, E.A.10
  • 35
    • 70449645182 scopus 로고    scopus 로고
    • T1N0 triple negative breast cancer: Risk of recurrence and adjuvant chemotherapy
    • 10.1111/j.1524-4741.2009.00789.x 19671105 10.1111/j.1524-4741.2009.00789. x
    • Kaplan HG, Malmgren JA, Atwood M (2009) T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy. Breast J 15:454-460. doi: 10.1111/j.1524-4741.2009.00789.x
    • (2009) Breast J , vol.15 , pp. 454-460
    • Kaplan, H.G.1    Malmgren, J.A.2    Atwood, M.3
  • 36
    • 82955233117 scopus 로고    scopus 로고
    • Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
    • 10.1002/cncr.26171 21681735 10.1002/cncr.26171 1:CAS:528: DC%2BC3MXhsFGktrrN
    • McArthur HL, Mahoney KM, Morris PG, Patil S, Jacks LM, Howard J, Norton L, Hudis CA (2011) Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer. Cancer 117:5461-5468. doi: 10.1002/cncr.26171
    • (2011) Cancer , vol.117 , pp. 5461-5468
    • McArthur, H.L.1    Mahoney, K.M.2    Morris, P.G.3    Patil, S.4    Jacks, L.M.5    Howard, J.6    Norton, L.7    Hudis, C.A.8
  • 38
    • 0037108675 scopus 로고    scopus 로고
    • National Surgical Adjuvant Breast and Bowel Project. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less
    • 12377957 10.1200/JCO.2002.11.101 1:CAS:528:DC%2BD38XnsFyqsLg%3D
    • Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S, Pisansky TM, Wolmark N, National Surgical Adjuvant Breast and Bowel Project (2002) Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149. doi: 10.1200/JCO.2002.11.101
    • (2002) J Clin Oncol , vol.20 , pp. 4141-4149
    • Fisher, B.1    Bryant, J.2    Dignam, J.J.3    Wickerham, D.L.4    Mamounas, E.P.5    Fisher, E.R.6    Margolese, R.G.7    Nesbitt, L.8    Paik, S.9    Pisansky, T.M.10    Wolmark, N.11
  • 39
    • 34548533485 scopus 로고    scopus 로고
    • Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
    • 10.1200/JCO.2006.10.4976 17664460 10.1200/JCO.2006.10.4976 1:CAS:528:DC%2BD2sXhtFanu7zI
    • Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25:3808-3815. doi: 10.1200/JCO.2006.10.4976
    • (2007) J Clin Oncol , vol.25 , pp. 3808-3815
    • Pinder, M.C.1    Duan, Z.2    Goodwin, J.S.3    Hortobagyi, G.N.4    Giordano, S.H.5
  • 41
    • 72449125237 scopus 로고    scopus 로고
    • Relationship between age at diagnosis and outcome of premenopausal breast cancer: Age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer
    • 10.1007/s10549-009-0388-z 19350387 10.1007/s10549-009-0388-z
    • Han W, Kang SY (2010) Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 119:193-200. doi: 10.1007/s10549-009-0388-z
    • (2010) Breast Cancer Res Treat , vol.119 , pp. 193-200
    • Han, W.1    Kang, S.Y.2
  • 43
    • 82155176361 scopus 로고    scopus 로고
    • T1abN0M0 HER2+ invasive breast cancer recurrence: Population-based cohort of 17,000+ consecutive breast cancers 2000-2006 at Kaiser Permanente Northern California (KPNC)
    • abstract 551
    • Fehrenbacher L, Shiraz P, Sattavat M, Capra A, Quesenberry C, Fulton R, Habel LA (2011) T1abN0M0 HER2+ invasive breast cancer recurrence: Population-based cohort of 17,000+ consecutive breast cancers 2000-2006 at Kaiser Permanente Northern California (KPNC). J Clin Oncol 29, No 15-suppl: abstract 551
    • (2011) J Clin Oncol , vol.29 , Issue.15 SUPPL.
    • Fehrenbacher, L.1    Shiraz, P.2    Sattavat, M.3    Capra, A.4    Quesenberry, C.5    Fulton, R.6    Habel, L.A.7
  • 47
    • 84860496688 scopus 로고    scopus 로고
    • Apocrine carcinoma as triple-negative breast cancer: Novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma
    • 10.1093/jjco/hys034 22450930 10.1093/jjco/hys034
    • Tsutsumi Y (2012) Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Jpn J Clin Oncol 42:375-386. doi: 10.1093/jjco/hys034
    • (2012) Jpn J Clin Oncol , vol.42 , pp. 375-386
    • Tsutsumi, Y.1
  • 48
    • 79952654970 scopus 로고    scopus 로고
    • Molecular stratification of triple-negative breast cancers
    • 10.1634/theoncologist.2010-S5-39 21138954 10.1634/theoncologist.2010-S5- 39 1:CAS:528:DC%2BC3MXltlWjsQ%3D%3D
    • Perou CM (2010) Molecular stratification of triple-negative breast cancers. Oncologist 15(Suppl 5):39-48. doi: 10.1634/theoncologist.2010-S5-39
    • (2010) Oncologist , vol.15 , Issue.SUPPL. 5 , pp. 39-48
    • Perou, C.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.